Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 23,500 | reported | 22 Jun 2022 | tx 19+5,116,719−35,452,939 |
| Korro Bio, Inc. | 14,846 | reported | 21 Jun 2022 | tx 19+616,518−3,086,958 |
| OPNET TECHNOLOGIES INC | 5,290 | reported | 18 Dec 2012 | tx 174+588,673−3,552,938 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jun 2022 | GRANT_AWARD | C4 Therapeutics, Inc. | 23,500 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | Korro Bio, Inc. | 14,846 | 0.00 USD | deriv |
| 04 Jan 2022 | GRANT_AWARD | C4 Therapeutics, Inc. | 657 | 31.58 USD | |
| 04 Oct 2021 | GRANT_AWARD | C4 Therapeutics, Inc. | 461 | 44.99 USD | |
| 02 Jul 2021 | GRANT_AWARD | C4 Therapeutics, Inc. | 522 | 39.72 USD | |
| 17 Jun 2021 | GRANT_AWARD | Korro Bio, Inc. | 14,846 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | C4 Therapeutics, Inc. | 23,500 | 0.00 USD | deriv |
| 14 Jun 2021 | OTHER | C4 Therapeutics, Inc. | 92,817 | 0.00 USD | |
| 14 Jun 2021 | OTHER | C4 Therapeutics, Inc. | 22,598 | 0.00 USD | |
| 05 Apr 2021 | GRANT_AWARD | C4 Therapeutics, Inc. | 553 | 37.51 USD | |
| 18 Feb 2021 | EXERCISE | C4 Therapeutics, Inc. | 536 | 2.11 USD | |
| 18 Feb 2021 | EXERCISE | C4 Therapeutics, Inc. | 536 | 0.00 USD | deriv |
| 06 Oct 2020 | PURCHASE | C4 Therapeutics, Inc. | 5,030 | 19.00 USD | |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 237,149 | — | |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 1,482,183 | — | |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 2,484,425 | — | |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 20,952,403 | 0.00 USD | deriv |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 12,500,000 | 0.00 USD | deriv |
| 06 Oct 2020 | CONVERSION | C4 Therapeutics, Inc. | 2,000,000 | 0.00 USD | deriv |
| 01 Oct 2020 | GRANT_AWARD | C4 Therapeutics, Inc. | 17,786 | 0.00 USD | deriv |
| 01 Oct 2020 | GRANT_AWARD | C4 Therapeutics, Inc. | 725,002 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | Korro Bio, Inc. | 14,846 | 0.00 USD | deriv |
| 30 Jan 2020 | EXERCISE | Korro Bio, Inc. | 20,778 | 3.37 USD | |
| 30 Jan 2020 | EXERCISE | Korro Bio, Inc. | 8,042 | 0.61 USD | |
| 30 Jan 2020 | EXERCISE | Korro Bio, Inc. | 16,691 | 0.61 USD |
1 purchase reported after at least 12 months of silence — most recent on 07 Oct 2019.